Largest positions
| Issuer | Class | Value | Share |
|---|---|---|---|
| Ligand Pharmaceuticals Inc.COM NEW | COM NEW | $85.4M | 4.2% |
| Aci Worldwide Inc.COM | COM | $50.6M | 2.5% |
| Arlo Technologies Inc.COM | COM | $50.3M | 2.4% |
| FabrinetSHS | SHS | $49.2M | 2.4% |
| Establishment Labs Hldgs Inc.COM | COM | $48.1M | 2.3% |
| Xpo Inc.COM | COM | $46.2M | 2.2% |
| Ziff Davis Inc.COM | COM | $43M | 2.1% |
| Shift4 Pmts Inc.CL A | CL A | $42.5M | 2.1% |
| Kiniksa Pharmaceuticals IntlORD SHS CL A | ORD SHS CL A | $40M | 1.9% |
| Ascendis Pharma A/sORD SHS | ORD SHS | $39.6M | 1.9% |
| Stride Inc.COM | COM | $37.9M | 1.8% |
| Prestige Consmr Healthcare ICOM | COM | $32.6M | 1.6% |
| Donnelley Finl Solutions Inc.COM | COM | $32.5M | 1.6% |
| Ituran Location And ControlSHS | SHS | $29M | 1.4% |
| Medpace Hldgs Inc.COM | COM | $28.7M | 1.4% |
| Armstrong World Inds Inc. NewCOM | COM | $28.4M | 1.4% |
| Godaddy Inc.CL A | CL A | $28.1M | 1.4% |
| Birkenstock Holding PLCCOM SHS | COM SHS | $27.1M | 1.3% |
| Clear Secure Inc.COM CL A | COM CL A | $27M | 1.3% |
| Ingevity Corp.COM | COM | $26.2M | 1.3% |
| Wex Inc.COM | COM | $25.2M | 1.2% |
| Sportradar Group AGCLASS A ORD SHS | CLASS A ORD SHS | $23.9M | 1.2% |
| Liquidity Svcs Inc.COM | COM | $23.8M | 1.2% |
| Federal Agric Mtg Corp.CL C | CL C | $23.5M | 1.1% |
| Biocryst Pharmaceuticals Inc.COM | COM | $23.3M | 1.1% |
| Upwork Inc.COM | COM | $23.2M | 1.1% |
| Genpact LimitedSHS | SHS | $22.9M | 1.1% |
| Supernus PharmaceuticalsCOM | COM | $22.8M | 1.1% |
| Viridian Therapeutics Inc.COM | COM | $21.6M | 1.1% |
| Radware LtdORD | ORD | $21M | 1.0% |
| Alkermes PLCSHS | SHS | $20.5M | 1.0% |
| Nexxen Intl LtdSHS NEW | SHS NEW | $19.7M | 1.0% |
| Progress Software Corp.COM | COM | $19.1M | 0.9% |
| Quidelortho Corp.COM | COM | $18.6M | 0.9% |
| Lemaitre Vascular Inc.COM | COM | $18.2M | 0.9% |
| Euronet Worldwide Inc.COM | COM | $18.1M | 0.9% |
| Lkq Corp.COM | COM | $17.9M | 0.9% |
| Wix Com LtdSHS | SHS | $17.4M | 0.8% |
| Neurocrine Biosciences Inc.COM | COM | $16.9M | 0.8% |
| Harrow Inc.COM | COM | $16.5M | 0.8% |
| Oshkosh Corp.COM | COM | $16.3M | 0.8% |
| Vail Resorts Inc.COM | COM | $15.9M | 0.8% |
| Acadia Pharmaceuticals Inc.COM | COM | $15.7M | 0.8% |
| Lci IndsCOM | COM | $15.1M | 0.7% |
| Varex Imaging Corp.COM | COM | $15.1M | 0.7% |
| Maximus Inc.COM | COM | $15M | 0.7% |
| Biomarin Pharmaceutical Inc.COM | COM | $14.2M | 0.7% |
| Taysha Gene Therapies Inc.COM SHS | COM SHS | $13.6M | 0.7% |
| Bank Ozk Little Rock ArkCOM | COM | $13.5M | 0.7% |
| Mirum Pharmaceuticals Inc.COM | COM | $13M | 0.6% |
- Class
- COM NEW
- Share
- 4.2%
- Class
- COM
- Share
- 2.5%
- Class
- COM
- Share
- 2.4%
- Class
- SHS
- Share
- 2.4%
- Class
- COM
- Share
- 2.3%
- Class
- COM
- Share
- 2.2%
- Class
- COM
- Share
- 2.1%
- Class
- CL A
- Share
- 2.1%
- Class
- ORD SHS CL A
- Share
- 1.9%
- Class
- ORD SHS
- Share
- 1.9%
- Class
- COM
- Share
- 1.8%
- Class
- COM
- Share
- 1.6%
- Class
- COM
- Share
- 1.6%
- Class
- SHS
- Share
- 1.4%
- Class
- COM
- Share
- 1.4%
- Class
- COM
- Share
- 1.4%
- Class
- CL A
- Share
- 1.4%
- Class
- COM SHS
- Share
- 1.3%
- Class
- COM CL A
- Share
- 1.3%
- Class
- COM
- Share
- 1.3%
- Class
- COM
- Share
- 1.2%
- Class
- CLASS A ORD SHS
- Share
- 1.2%
- Class
- COM
- Share
- 1.2%
- Class
- CL C
- Share
- 1.1%
- Class
- COM
- Share
- 1.1%
- Class
- COM
- Share
- 1.1%
- Class
- SHS
- Share
- 1.1%
- Class
- COM
- Share
- 1.1%
- Class
- COM
- Share
- 1.1%
- Class
- ORD
- Share
- 1.0%
- Class
- SHS
- Share
- 1.0%
- Class
- SHS NEW
- Share
- 1.0%
- Class
- COM
- Share
- 0.9%
- Class
- COM
- Share
- 0.9%
- Class
- COM
- Share
- 0.9%
- Class
- COM
- Share
- 0.9%
- Class
- COM
- Share
- 0.9%
- Class
- SHS
- Share
- 0.8%
- Class
- COM
- Share
- 0.8%
- Class
- COM
- Share
- 0.8%
- Class
- COM
- Share
- 0.8%
- Class
- COM
- Share
- 0.8%
- Class
- COM
- Share
- 0.8%
- Class
- COM
- Share
- 0.7%
- Class
- COM
- Share
- 0.7%
- Class
- COM
- Share
- 0.7%
- Class
- COM
- Share
- 0.7%
- Class
- COM SHS
- Share
- 0.7%
- Class
- COM
- Share
- 0.7%
- Class
- COM
- Share
- 0.6%
The share class is shown on a wider screen.
The 50 largest of 240 positions by value, with holdings of the same security combined. The 200 largest are in this firm's machine-readable record. Share counts and quarter-on-quarter changes for each position are on EDGAR. View the full information table on EDGAR
This filing
- Form
- 13F-HR
- CIK
- 1230765
- File number
- 028-10467
- Options
- 0 call, 0 put
- In the 25 largest
- 44.4%
- Prior quarter
- $1.8B at 31 March 2026
- Positions opened
- 14
- Positions closed
- 17
Common questions
What are Rice Hall James & Associates’ 13F holdings worth?
$2.05 billion across 240 positions for the quarter ended 30 June 2026.
What is Rice Hall James & Associates’ largest 13F holding?
LIGAND PHARMACEUTICALS INC (COM NEW) was the largest position at $85.4 million, or 4.2% of reported 13F value, as of 30 June 2026.
How concentrated is Rice Hall James & Associates’ 13F portfolio?
The ten largest positions accounted for 24.1% of reported value and the twenty-five largest for 44.4%, across 240 positions as of 30 June 2026.
Does Form 13F show everything Rice Hall James & Associates manages?
No. Form 13F covers only long positions in exchange-traded securities over which the manager has investment discretion, valued at quarter end. It excludes cash, most bonds, private funds, and any assets the firm does not have discretion over, so it is neither the firm's total assets nor any individual client's portfolio.
How often does Rice Hall James & Associates file its 13F?
Every quarter. Managers file within 45 days of each quarter's end, so the figures are a snapshot that changes between filings. This page shows the quarter ended 30 June 2026.
Answered from this filing and the prior quarter's.